Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation

Nature Genetics

Volumn 36, Issue 3, 2004, Pages 257-263

  Stegmaier, Kimberly ^a   Ross, Kenneth N ^b   Colavito, Sierra A ^a   O'Malley, Shawn ^c   Stockwell, Brent R ^b   Golub, Todd R ^a,b,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CHEMOTAXONOMY; DRUG IDENTIFICATION; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GENE EXPRESSION REGULATION; HIGH THROUGHPUT SCREENING; HUMAN; LEUKEMIA; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELIABILITY; STRUCTURE ANALYSIS;

ACUTE DISEASE; CELL DIFFERENTIATION; GENE EXPRESSION; GENETIC TECHNIQUES; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; PROTEIN ARRAY ANALYSIS;

EID: 1442335997     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1305     Document Type: Article

References (30)

1. Peterson, R.T., Link, B.A., Dowling, J.E. & Schreiber, S.L. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. USA 97, 12965-12969 (2000).
2. Mayer, T.U. et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971-974 (1999).
3. Grozinger, C.M., Chao, E.D., Blackwell, H.E., Moazed, D. & Schreiber, S.L. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J. Biol. Chem. 276, 38837-38843 (2001).
4. Clemons, P.A. et al. A one-bead, one-stock solution approach to chemical genetics: part 2. Chem. Biol. 8, 1183-1195 (2001).
5. Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674 (1991).
6. Huang, M.E. et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567-572 (1988).
7. Seiter, K. et al. Clinical and laboratory evaluation of all-trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukaemia. Br. J. Haematol. 108, 40-47 (2000).
8. Sokoloski, J.A., Blair, O.C. & Sartorelli, A.C. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5′-phosphate dehydrogenase. Cancer Res. 46, 2314-2319 (1986).
9. Yeakley, J.M. et al. Profiling alternative splicing on fiber-optic arrays. Nat. Biotechnol. 20, 353-358 (2002).
10. Yang, L., Tran, D.K. & Wang, X. BADGE, Beads Array for the Detection of Gene Expression, a high-throughput diagnostic bioassay. Genome Res. 11, 1888-1898 (2001).
11. Root, D.E., Flaherty, S.P., Kelley, B.P. & Stockwell, B.R. Biological mechanism profiling using an annotated compound library. Chem. Biol. 10, 881-892 (2003).
12. Bodner, A.J., Ting, R.C. & Gallo, R.C. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J. Natl. Cancer Inst. 67, 1025-1030 (1981).
13. Kalinyak, K.A., Sawutz, D.G., Lampkin, B.C., Johnson, C.L. & Whitsett, J.A. Effects of dimaprit on growth and differentiation of human promyelocytic cell line, HL-60. Life Sci. 36, 1909-1916 (1985).
14. Fici, G.J., Wu, H., VonVoigtlander, P.F. & Sethy, V.H. D1 dopamine receptor activity of anti-parkinsonian drugs. Life Sci. 60, 1597-1603 (1997).
15. Perachon, S., Schwartz, J.C. & Sokoloff, P. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. Eur. J. Pharmacol. 366, 293-300 (1999).
16. Duncan, G.S., Wolberg, G., Schmitges, C.J., Deeprose, R.D. & Zimmerman, T.P. Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine. J. Immunopharmacol. 4, 79-100 (1982).
17. Dubey, R.K. et al. Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway. Hypertension 35, 262-266 (2000).
18. Guillemin, M.C. et al. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J. Exp. Med. 196, 1373-1380 (2002).
19. Mountford, J.C. et al. Estrone potentiates myeloid cell differentiation: a role for 17 beta-hydroxysteroid dehydrogenase in modulating hemopoiesis. Exp. Hematol. 27, 451-460 (1999).
20. Shim, G.J. et al. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. Acad. Sci. USA 100, 6694-6699 (2003).
21. McBurney, M.W. & Whitmore, G.F. Mechanism of growth inhibition by methotrexate. Cancer Res. 35, 586-590 (1975).
22. Reyes, P. & Heidelberger, C. Fluorinated pyrimidines. XXVI. Mammalian thymidylate synthetase: its mechanism of action and inhibition by fluorinated nucleotides. Mol. Pharmacol. 1, 14-30 (1965).
23. Ben-Baruch, N. et al. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation. Mol. Pharmacol. 46, 73-78 (1994).
24. Baker, K. et al. Chemical complementation: a reaction-independent genetic assay for enzyme catalysis. Proc. Natl. Acad. Sci. USA 99, 16537-16542 (2002).
25. Stockwell, B.R., Haggarty, S.J. & Schreiber, S.L. High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6, 71-83 (1999).
26. Barrie, S.E. et al. High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells. Anal. Biochem. 320, 66-74 (2003).
27. Johnson, P.H. et al. Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells. Mol. Cancer Ther. 1, 1293-1304 (2002).
28. Golub, T.R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
29. Mantel, N. The detection of disease clustering and a generalized regression approach. Cancer Res. 27, 209-220 (1967).
30. Harvath, L. & Terle, D.A. Assay for phagocytosis. Methods Mol. Biol. 115, 281-290 (1999).